SELECTIVE KINASE INHIBITORS BASED ON PYRIDINE SCAFFOLD

There is described a compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms, and isomeric forms thereof, a pharmaceutical composition comprising a compound of general formula (I), a method for the treatment of a tyrosine kinase-associate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KLING, MARCEL, ROBERT, BURNS, CHRIS, JOHN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	There is described a compound of the general formula (I) or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms, and isomeric forms thereof, a pharmaceutical composition comprising a compound of general formula (I), a method for the treatment of a tyrosine kinase-associated disease state and a method of suppressing the immune system using a compound of general formula (I). L'invention concerne un composé de formule générale I ou ses promédicaments, sels, hydrates, solvates, formes cristallines et formes isomériques pharmaceutiquement acceptables, une composition pharmaceutique comprenant un composé de formule générale I, un procédé de traitement d'une maladie associée à la tyrosine kinase et un procédé de suppression du système immunitaire au moyen d'un composé de formule générale I.